Chapter 22 022
Jared stood in the quiet lab looking at the Mark Two prototype for a long moment.
The device sat on the bench looking unremarkable to anyone who did not understand what it represented. But his Medical Expertise skill was running a full assessment and the picture it produced was anything but unremarkable.
The original RapidCore device had been positioned as a clinical screening tool. Hospitals, urgent care facilities, cardiology practices. A valuable market but a bounded one with long procurement cycles, institutional bureaucracy, and insurance reimbursement complexity that could slow commercial traction by years.
The Mark Two changed the entire equation.
Ninety second wireless results meant the device could operate in environments where speed was the difference between life and death. Ambulances. Fire stations. Sports facilities. Remote communities without immediate hospital access. The addressable market was not just larger. It was structurally different. Faster moving. Less institutionally encumbered.
And nobody outside this room knew it existed yet.
Jared turned to Vore. "How long until the Mark Two is ready for regulatory submission."
"Six months if we have the capital to run the clinical validation trials in parallel with the submission preparation," Vore said. "Twelve months if we sequence them."
"What does parallel look like in terms of capital requirement."
Vore pulled a document from a folder on the bench. He had prepared for this question. "Four point two million above what the consortium has already committed."
Jared looked at the document. The trial design was thorough and the budget was not padded. Vore had clearly written it himself rather than having it dressed up for investor presentation.
"I will cover it personally outside the consortium structure," Jared said.
Vore looked at him carefully. "That would give you a direct stake in the Mark Two separate from the consortium position."
"Yes," Jared said. "Is that acceptable to you."
A pause. "It depends on the terms."
"Simple terms," Jared said. "Four point two million from Knox Holdings directly in exchange for an eight percent stake in the Mark Two commercialization entity when it is established. The consortium retains its position in the original RapidCore structure without dilution. Clean separation."
\[System Notification: Negotiation Mastery active. Offer construction assessed as fair and strategically optimal. Vore receptivity — high.\]
Vore read the terms as Jared had stated them aloud. The scientist in him was processing the mathematics. The founder in him was assessing whether control was being compromised.
Both arrived at the same answer.
"I want it in writing by Friday," Vore said.
"You will have it by Thursday," Jared replied.
They shook hands over the Mark Two prototype in the quiet Long Beach lab and something shifted in the room that both men felt without naming it.
\[System Notification: Direct investment in Helix Bio Mark Two secured. Knox Holdings stake in next generation cardiac screening technology confirmed. Medical Expertise Advanced Level flagging this as highest potential single asset in current portfolio.\]
On the drive back to Los Angeles Jared called Anita.
He outlined the four point two million deployment and the terms. Anita listened without interrupting which meant she was processing rather than objecting.
"That deploys a significant portion of your liquid reserve," she said when he finished.
"I know," Jared said.
"You are comfortable with the liquidity position afterward."
"The credit facility covers any operational gap," Jared said. "And the Mark Two changes the Helix Bio valuation picture in ways that make the four point two look very small within eighteen months."
Another pause. "Send me the technical summary."
"Vore will send it directly," Jared said. "He anticipated you would want it."
Anita made the recalibration sound. "I am beginning to think you plan these conversations before you have them."
"Always," Jared said.
He was back at the penthouse by two in the afternoon. He made coffee and stood at the window and opened the Destiny Network map on his status panel.
The map had updated since Monday. Two new nodes had appeared connected to Gerald Ashton's position. The system had flagged them as pending introductions based on Ashton's stated interest in reviewing the Knox Holdings pipeline.
He studied their profiles.
Eleanor Bright. Sixty three years old. Ran a family office called Bright Capital with a seven hundred million dollar portfolio concentrated heavily in California healthcare and infrastructure assets. She had been Gerald Ashton's investment partner on three deals over the past decade and moved when Ashton moved on anything he considered genuinely compelling.
The second name was simpler and heavier.
James Wolfe. Fifty eight. Founder and sole principal of Wolfe Pacific Investments. Portfolio value undisclosed publicly but estimated by three separate analyst notes at somewhere between one point eight and two point four billion dollars. Ranked eleventh on the California Wealthiest Individuals list.
Number eleven.
\[System Notification: High value nodes detected in proximity network. Destiny Network recommending engagement pathway through Gerald Ashton introduction. Timing optimal within 14 days.\]
Jared set his coffee down and looked at the map for a long time.
Eleven on the California list was not a cautious partner or a development contact. Eleven was a different category of conversation entirely. The kind that did not happen through golf rounds or consortium meetings or private dining rooms.
The kind that happened because someone at that level decided you were worth their time and reached out directly.
His phone buzzed.
A message from Gerald Ashton.
It was four words.
James Wolfe called me.
Jared read it twice then set the phone face down on the desk and looked out at the city.
\[System Notification: Destiny Network engagement accelerating beyond projected timeline. Prepare for significant inflection point within 72 hours.\]
Seventy two hours.
He picked the phone back up and typed a single reply to Ashton.
What did he say.
Ashton's response came ninety seconds later.
He wants to meet you. Thursday. His office. He does not do anything other than his office for first meetings. I told him you would be there.
Jared looked at the message for a moment.
Number eleven on the California list had called number twenty three to arrange a meeting with someone currently sitting at one hundred and thirty eight million in assets.
That did not happen because of momentum alone.
That happened because the Destiny Network was doing exactly what the system had designed it to do. Pulling threads that connected people across distances that should have taken years to close.
He typed back to Ashton.
Tell him Thursday works.
Then he opened his full status panel and looked at the complete picture.
\[Name: Jared Knox\]
\[Level: 10 (31/500)\]
\[Title: California Predator\]
\[Skills: Medical Expertise (Advanced), Charisma Boost (Advanced), Property Management (Master), Market Intelligence (Passive), Business Intelligence (Beginner), Negotiation Mastery (Intermediate), Leadership Mastery (Advanced), Athletics Coordination (Beginner)\]
\[Total Asset Value: $138,600,000\]
\[Pending: Helix Bio Mark Two direct stake — 8 percent\]
\[Active Mission: California Top 100 Wealthiest — 129 days remaining\]
One hundred and twenty nine days.
James Wolfe on Thursday.
Eleanor Bright somewhere behind that.
The Destiny Network map glowed quietly in his status panel with its lines and nodes and the invisible architecture of a future that was assembling itself faster than even the system had projected.
Jared Knox finished his coffee and started preparing for Thursday.